RGR — what changed in the latest 10-Q

Text added vs the prior filing · source: 10-Q · 2026-07-29

• · The appointment of a new CFO in April of 2026, along with other ongoing organizational realignment designed to improve efficiency and effectiveness.

• · The Company entered into an agreement with Beretta Holding S.A. (“Beretta”), resolving the potential proxy fight and eliminating distractions.

• Net sales, cost of products sold, and gross profit data for the six months ended (dollars in millions):

• The increase in total consolidated net sales and net firearms sales for the six months ended June 27, 2026 is attributable to increased demand, augmented by an increased average selling price. Sales of new products, including the RXM pistol, Super Wrangler revolver, Marlin lever-action rifles, and (…

• The increased gross profit for the six months ended June 27, 2026 is attributable to the aforementioned sales increases, the absence of inventory rationalization write-offs that were undertaken in the prior year, and the favorable leveraging of fixed costs resulting from increased production, partia…

Text removed vs the prior filing · source: 10-Q · 2026-05-06

• ·The Company’s Board of Directors advancing a deliberate and independent refreshment process, which saw the retirement of three existing directors and the addition of three new directors with relevant operational, industrial and strategic expertise while maintaining continuity during a period of lea…

• ·The appointment of a new CFO in April of 2026, along with other ongoing organizational realignment designed to improve efficiency and effectiveness.

• Selling expenses for the three months ended March 28, 2026 were substantially comparable to the corresponding period in the prior year.

• The increase in general and administrative expenses for the three months ended March 28, 2026 was primarily attributable to $3.2 million in legal fees incurred related to the Beretta Strategic Cooperation Agreement, $2.5 million in severance costs, increased to share based compensation, which includ…

• The increase in other income for the three months ended March 28, 2026 was attributable to increased royalty income.

Text added vs the prior filing · source: 10-Q · 2026-07-29

• During the three months ending June 27, 2026, the previously reported case of City of Gary v. Smith & Wesson, et al., was dismissed by the court with prejudice.

Text removed vs the prior filing · source: 10-Q · 2026-05-06

• During the three months ending March 28, 2026, the previously reported case of Thompson v. Sturm, Ruger & Company, Inc., was withdrawn by the plaintiff.

Text added vs the prior filing · source: 10-Q · 2026-07-29

• The adoption or termination of contracts, instructions or written plans for the purchase and sale of the Company’s securities by the Company’s Section 16 officers or directors during the three months ended June 27, 2026, each of which is intended to satisfy the affirmative defense conditions of Rule…

• Michael W. Wilson (2) Vice President of Administration Adoption of Rule 10b5-1 Plan May 18, 2026 June 1, 2027 1,828

• (1) John A. Cosentino, Jr., a director of the Company, entered into a Rule 10b5-1 Plan on May 27, 2026. Mr. Cosentino’s Rule 10b5-1 Plan provides for the potential purchase of up to 20,000 shares and/or sale of up to 20,000 shares of the Company’s common stock. The Rule 10b5-1 Plan expires on May 27…

• (2) Michael W. Wilson, an officer of the Company, entered into a Rule 10b5-1 Plan on May 18, 2026. Mr. Wilson’s Rule 10b5-1 Plan provides for the potential sale of up to 1,828 shares of the Company’s common stock. The Rule 10b5-1 Plan expires on June 1, 2027, or upon the earlier completion of all au…

• None of the Company’s directors or Section 16 officers adopted or terminated a “non-Rule 10b5-1 trading arrangement” as defined in Item 408 of Regulation S-K during the three months ended June 27, 2026.

Text removed vs the prior filing · source: 10-Q · 2026-05-06

• There were no contracts, instructions or written plans for the purchase and sale of the Company’s securities, intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (“Rule 10b5-1 Plan”), adopted or terminated by the Company’s Section 16 officers or directors …

• None of the Company’s directors or Section 16 officers adopted or terminated a “non-Rule 10b5-1 trading arrangement” as defined in Item 408 of Regulation S-K during the three months ended March 28, 2026.